PLIVA 518 (Theophylline extended-release 450 mg)

Pill imprint PLIVA 518 has been identified as Theophylline extended-release 450 mg.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 450 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for PLIVA 518

Theophylline extended-release 450 mg PLIVA 518
Theophylline extended-release 450 mg PLIVA 518
Theophylline extended-release
Imprint:
PLIVA 518
Strength:
450 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pliva Inc.
National Drug Code (NDC):
50111-0518
Inactive Ingredients:
hypromellose 2208 (100 mPa.s)
lactose anhydrous
magnesium stearate
povidone

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)